The journey to develop an upstream bioprocess is complex, involving process development, optimization and scale-up. Hence, it’s important to choose the right equipment to accelerate this journey while ...

After Repligen (RGEN) announced that it has purchased 908 Devices’ (MASS) desktop portfolio of four devices for bioprocessing process ...

However, 3D Bioprocess Containers are expected to register ... The market analysis by applications indicates that upstream processes, which include cell culture and fermentation, hold a leading ...

About Culture Biosciences Culture Biosciences is dedicated to innovation in upstream bioprocess development. Culture’s goal is to build new tools and services that improve the performance ...

Upstream Processing, Downstream Processing, and Analytical and Quality, to Cell, Gene and Nucleic Therapies (Novel Modalities)- Manufacturing and Analytics, and Bioprocess Manufacturing. Whether ...

By eliminating the need to send bioreactor samples to a central laboratory for analysis, the new solutions make it even easier to accelerate upstream bioprocess development by up to six weeks over ...

Olivier Loeillot, President and Chief Executive Officer at Repligen said, “We are really excited to onboard the 908 bioprocessing team and the four differentiated upstream PAT technologies that ...

The monetary consideration of Repligen's purchase of 908 Devices' bioprocess analytics portfolio is a payment of $70 million in cash.

However, 3D Bioprocess Containers are expected to register the fastest growth during the forecast period owing to their enhanced capability to support complex biologics production. The market analysis ...